Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn's Disease: Results from the Phase 2 Open-Label Extension Study. - Ferrante, Marc; Feagan, Brian G; Panés, Julián; Baert, Filip; Louis, Edouard; Dewit, Olivier; Kaser, Arthur; Duan, W Rachel; Pang, Yinuo; Lee, Wan-Ju; Gustafson, Dawn; Liao, Xiaomei; et al. (Journal of Crohn's & Colitis, 2021)